Teva Pharmaceuticals sued Philadelphia-based Amicus Therapeutics Tuesday in Pennsylvania Eastern District Court over the drugmaker's alleged refusal to provide access to product samples in accordance with the federal CREATES Act. The law, enacted in 2019, provides a timeline and mechanism for generic drugmakers to obtain samples of approved medications to support new generic drug applications. The suit, filed by Shook, Hardy & Bacon, accuses Amicus of withholding samples of its Galafold treatment for Fabry disease. Counsel have not yet appeared for the defendant. The case is 2:21-cv-03105, Teva Pharmaceuticals Development, Inc., v. Amicus Therapeutics U.S., Inc.
Biotech & Pharmaceuticals
July 13, 2021, 3:05 PM